Earnings Call Summary | Charles River(CRL.US) Q1 2024 Earnings Conference
Earnings Call Summary | Charles River(CRL.US) Q1 2024 Earnings Conference
The following is a summary of the Charles River Laboratories International, Inc. (CRL) Q1 2024 Earnings Call Transcript:
以下是查爾斯河實驗室國際公司（CRL）2024年第一季度業績電話會議記錄摘要：
Financial Performance:
財務業績：
Charles River Laboratories reported Q1 2024 revenue of $1.01 billion, a decrease of 1.7%, with an organic revenue decline of 3.3%.
Earnings per share were $2.27 in Q1, a decrease of 18.3% from Q1 last year.
The operating margin was 18.5%, a decrease of 270 basis points year-over-year.
A solid performance from the Manufacturing and RMS segments was offset by the expected decline in DSA revenue.
查爾斯河實驗室報告稱，2024年第一季度收入爲10.1億美元，下降1.7％，有機收入下降3.3％。
第一季度每股收益爲2.27美元，比去年第一季度下降18.3％。
營業利潤率爲18.5％，同比下降270個點子。
製造業和RMS板塊的穩健表現被DSA收入的預期下降所抵消。
Business Progress:
業務進展：
Charles River Laboratories launched the Alternative Message Advancement Project (AMAP) focusing on reducing animal testing and plans to invest an additional $300 million.
The company indicates a high degree of confidence in acceleration of business in the latter half of the year.
Despite price cuts and lower funding levels, there's an increase in proposal activities and retention of capacity to handle larger workloads.
Ongoing restructuring initiatives are expected to yield $70 million in annual savings.
The company is actively monitoring the BIOSECURE Act's potential impact and anticipates benefitting from its enactment.
Increased commercial activities and positive results from Q1 imply mid-single-digit growth for the Manufacturing business within the year.
查爾斯河實驗室啓動了替代信息推進項目（AMAP），重點是減少動物試驗，並計劃額外投資3億美元。
該公司對下半年業務加速充滿信心。
儘管降價和資金水平降低，但提案活動有所增加，處理更大工作量的能力也有所保留。
正在進行的重組計劃預計每年將節省7,000萬美元。
該公司正在積極監測《生物安全法》的潛在影響，並預計將從該法案的頒佈中受益。
第一季度商業活動的增加和積極的業績意味着製造業務在年內將實現中等個位數的增長。
More details: Charles River IR
更多詳情： 查爾斯河 IR
Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示：欲了解更多詳情，請訪問投資者關係網站。本文僅供投資者參考，不構成任何投資建議。
譯文內容由第三人軟體翻譯。